Stocks To Buy Now

Blog


Momentous Entertainment Group, Inc. (MMEG) Engages QualityStocks Corporate Communications Suite

Momentous Entertainment Group, Inc. (OTC: MMEG), a diversified entertainment and direct response marketing company, today announced that it has engaged the Corporate Communications Services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value over the past 10 years.

“We’ve got a lot of interesting initiatives in the works, which is typical for us at Momentous Entertainment,” says Momentous president and CEO Kurt Neubauer. “As we transition these unique ideas into marketable entertainment products — building on our current offerings — the QualityStocks team will make sure that the progress we’re making reaches our shareholders in a clear, consistent and transparent manner. We look forward to the increased visibility and awareness this partnership will deliver.”

Per the agreement, QualityStocks will strategically leverage its network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to ensure Momentous’ brand is relevant, consistent and transparent to the investment community.

“Momentous Entertainment is an exciting company to have on board, and we look forward to working closely with Kurt and the rest of the team to enhance the company’s communication strategies and share its progress and varied endeavors with shareholders,” says QualityStocks Managing Director Michael McCarthy.

For more information, visit www.momentousent.com

Let us hear your thoughts: Momentous Entertainment Group. Message Board

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year

February 12, 2026

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity […]

Rotate your device 90° to view site.